Q&A: FDA's Zineh Reviews 2010 Personalized Rx Efforts and Discusses Future Plans
January 05, 2011
Q&A: FDA's Zineh Reviews 2010 Personalized Rx Efforts and Discusses Future Plans
Zineh recently answered PGx Reporter's questions about the agency's efforts in pharmacogenomics and personalized medicine.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- NIH Launches Large Randomized Trial to Determine Utility of PGx-based Warfarin Dosing
February 18, 2009 / Pharmacogenomics Reporter - Q&A: CDRH's Gutierrez, Mansfield Discuss Ongoing Regulatory Efforts in Personalized Medicine
January 2, 2013 / Pharmacogenomics Reporter - People in the News: Issam Zineh
August 8, 2012 / Clinical Sequencing News - Seeking 510(k) Clearance for Genomic Testing Service, 23andMe Maintains Direct-to-Consumer Ethos
August 1, 2012 / Pharmacogenomics Reporter - FDA Issues Draft Guidance on Pre-Submission Program to Help Device Makers Gain Early Agency Feedback
July 18, 2012 / Pharmacogenomics Reporter